Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation

Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation

Abstract Purpose TNM Stage 3B encompasses a wide range of primary tumor and nodal metastatic tumor burden. This study aimed to evaluate the prognostic value of quantitative FDG PET/CT parameters in patients with newly diagnosed Stage 3B Non-Small Cell Lung Cancer (NSCLC). Materials and Methods Insti...

Full description

Bibliographic Details
Main Authors: Brittany Z. Dashevsky, Chenpeng Zhang, Li Yan, Cindy Yuan, Lingyun Xiong, Yongmei Liu, Haiyan Liu, Feng-Ming Spring Kong, Yonglin Pu
Format: Article
Language:English
Published: SpringerOpen 2017-12-01
Series:European Journal of Hybrid Imaging
Subjects:
Lung cancer
Tumor volume
FDG, PET/CT
Online Access:http://link.springer.com/article/10.1186/s41824-017-0013-z

Internet

http://link.springer.com/article/10.1186/s41824-017-0013-z

Similar Items